Form 4 Tracker
Taub Rebecca

Director · 4 filings · Latest: Jun 17, 2026

MADRIGAL PHARMACEUTICALS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
MDGL
Taub RebeccaDirectorMar 6, 2026
Sale
$431.94491$212.1K452,213
MDGL
Rebecca Taub—Mar 6, 2026
Proposed Sale
$439.34491$215.7K—
MDGL
Taub RebeccaDirectorJan 26, 2026
Sale
$492.42647$318.6K452,704
MDGL
Rebecca Taub—Jan 26, 2026
Proposed Sale
$480.45647$310.9K—
MDGL
Taub RebeccaDirectorJan 20, 2026
Sale
$490.772,238$1.1M453,351
MDGL
Rebecca Taub—Jan 20, 2026
Proposed Sale
$501.682,238$1.1M—
MDGL
REBECCA A TAUB—Jan 9, 2026
Proposed Sale
$556.2218,650$10.4M—
MDGL
REBECCA A TAUB—Dec 10, 2025
Proposed Sale
$553.9218,650$10.3M—
MDGL
REBECCA TAUB—Aug 12, 2025
Proposed Sale
$349.5043,263$15.1M—
MDGL
REBECCA TAUB—Aug 11, 2025
Proposed Sale
$345.733,200$1.1M—
MDGL
REBECCA TAUB—Jul 18, 2025
Proposed Sale
$348.731,000$348.7K—
MDGL
REBECCA TAUB—Jul 17, 2025
Proposed Sale
$344.972,657$916.6K—
MDGL
REBECCA TAUB—Jul 16, 2025
Proposed Sale
$311.1426,444$8.2M—
MDGL
Rebecca Taub—Jan 24, 2025
Proposed Sale
$340.14648$220.4K—
MDGL
Rebecca Taub—Jan 17, 2025
Proposed Sale
$272.791,689$460.7K—